eleclazine: Clinical Trials

2 trials of eleclazine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2
Phase 21Terminated 1

Follow eleclazine: new trials by email Literature Review of eleclazine trials Research Report on eleclazine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Eleclazine, Placebo - Hypertrophic Cardiomyopathy
Phase 2 / Phase 3TerminatedGilead Sciences1722015-02-052018-09-24
Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Eleclazine, Eleclazine placebo - Long QT Syndrome Type 3
Phase 3TerminatedGilead Sciences412014-12-172018-01-12

Conditions studied

Angina Pectoris (1)  ·  Cardiomyopathies (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Cardiomyopathy, Hypertrophic, Familial (1)  ·  Death, Sudden, Cardiac (1)  ·  Dyspnea (1)  ·  Heart Failure (1)  ·  Hypertrophy (1)  ·  Long QT Syndrome (1)  ·  Long QT syndrome type 3 (1)

Sponsors

Gilead Sciences (2)

Countries

France (2)  ·  Germany (2)  ·  Israel (2)  ·  Italy (2)  ·  Netherlands (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)

NIH funding

2014 (1)